Child & Adolescent Psychiatry

Explore new consensus guidelines on childhood stuttering, uniting psychiatry and neurology with practical treatment insights to improve patient care.

STARS experts redefine stuttering as a brain-based neuropsychiatric disorder, urging interdisciplinary care and warning dopamine-boosting ADHD or antidepressant meds may worsen symptoms.

Why teens use drugs and alcohol: avoidant attachment and emotional isolation fuel addiction; attachment-based therapy rebuilds bonds and cuts relapse.

Teens’ pre-bed smartphone scrolling drives more late-night phone use, disrupting sleep and potentially worsening mental health—experts urge bedtime screen limits and device-free bedrooms.

Lawsuits, research, and clinicians clash over youth screen addiction—learn more about how problematic social platform use evades diagnosis and how we can curb harm.

FDA issues CRL for CTx-1301 in ADHD.

New Surgeon General advisory warns of youth screen and social media harms, urging families, schools, and clinicians to act with the 5 Ds.

Massive Lancet meta-analysis suggests most use of antidepressants while pregnant does not raise autism or ADHD risk after confounders, easing treatment decisions.

ASAM’s new youth SUD criteria help clinicians deliver developmentally tailored, prevention-first care with coordinated family and community supports.

New ASAM youth criteria redefine SUD care with brain-stage levels, chronic monitoring, detox safety, and family-centered support.

Deep intracranial frequency stimulation 77.5 Hz high-gamma approach was associated with statistically significant reductions in self-injury behaviors and depressive symptoms in female adolescents with nonsuicidal self-injury.

ASAM announces new youth substance use disorder criteria, promoting early intervention, family-focused care, integrated mental health, and updated levels of treatment.

Dutch psychiatric euthanasia cases surge among young adults, sparking debate over irremediability, activism, and suicide contagion risks.

Here's what clinicians must do when patients admit viewing CSEM: more on state reporting rules, confidentiality limits, and why California is different.

Active Minds is pushing for 988 Lifeline information to be shared on student IDs, boosting crisis access and youth-led policy action to curb suicide and reshape campus support.

Congress backs printing 988 on student ID cards, boosting youth crisis access and funding.

An open letter urges lawmakers to regulate AI chatbots, highlighting their dangers to children's emotional development and mental health.

Tiffani Bell-Washington, MD, MPH shares insights on compassionate lifestyle changes for adolescents facing obesity, emphasizing collaboration and individualized care strategies.

Otsuka Pharmaceutical submits a new drug application for centanafadine for treatment of ADHD, showing significant efficacy across all age groups.

Take a look at the long-term effects of stimulant medications on ADHD, specifically tolerance and its implications for treatment efficacy.

FDA expands Deep TMS therapy for adolescents with major depressive disorder, offering a noninvasive treatment option for underserved youth.

Cingulate's CTx-1301 shows promising phase 3 results for ADHD, offering effective once-daily dosing and potential FDA approval by 2026.

Psychiatry explores extraordinary experiences like near-death experiences and out-of-body experiences, distinguishing them from mental illness to enhance patient care and understanding.

Chatbots engage youth with connection but pose serious risks, potentially harming mental health and fostering unhealthy attachments. Awareness and regulation are crucial.